20-06-2019 дата публикации
Номер: US20190185491A1
Принадлежит:
Embodiments of the present disclosure describe compositions comprising a molecular building block (MBB) having the formula [RE(μ-OH)(OC—)NC—)] or [RE(μ-OH)(OC—)], wherein RE is a rare earth metal ion. Embodiments of the present disclosure further describe methods of making a metal-organic framework (MOF) composition comprising contacting one or more molecular building blocks (MBBs) with one or more bidentate ligands, wherein the MBBs have the formula [RE(μ-OH)(OC—)NC—)] or [RE(μ-OH)(OC—)], wherein RE is a rare earth metal ion. 1. A composition , comprising: a molecular building block (MBB) having the formula [RE(μ-OH)(OC—)NC—)] , wherein RE is a rare earth metal ion.2. The composition of claim 1 , wherein the rare earth metal ion is selected from cerium claim 1 , dysprosium claim 1 , erbium claim 1 , europium claim 1 , gadolinium claim 1 , holmium claim 1 , lanthanum claim 1 , lutetium claim 1 , neodymium claim 1 , praseodymium claim 1 , promethium claim 1 , samarium claim 1 , scandium claim 1 , terbium claim 1 , thulium claim 1 , ytterbium claim 1 , yttrium claim 1 , and combinations thereof.3. The composition of claim 1 , further comprising a bidentate ligand.4. The composition of claim 3 , wherein the bidentate ligand includes one or more of carboxylates claim 3 , trizolates claim 3 , tetrazolates claim 3 , pyrazolates claim 3 , and fluoros.5. The composition of claim 4 , wherein the carboxylates include dicarboxylates.6. The composition of claim 4 , wherein the trizolates include ditrizolates.7. The composition of claim 4 , wherein the tetrazolates include ditetrazolates.8. The composition of claim 4 , wherein the pyrazolates include dipyrazolates.9. The composition of claim 3 , wherein the bidentate ligands include one or more of 2-fluoro-4-(1H-tetrazol-5-yl)benzoate (FTZB) claim 3 , 4-(1H-tetrazol-5-yl)benzoate (TZB) claim 3 , 3-fluoro-4′-(2H-tetrazol-5-yl)biphenyl-4-carboxylate (FTZBP) claim 3 , 3-fluorobiphenyl-4 claim 3 ,4′-dicarboxylate (FBPDC) claim 3 , ...
Подробнее